Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pitavastatin vs Simvastatin in Hypercholesterolemia
NCT00309777Phase 3Completed
- Sponsor
- Kowa Company, Ltd.
- Start
- Sep 2005
- Primary completion
- Oct 2006
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 3, randomised, double-blind trial of pitavastatin in hypercholesterolemia and combined dyslipidemia (4 arms), sponsored by Kowa Company, Ltd. Primary endpoint: Percent Change From Baseline in Low Density Lipoprotein-cholesterol at 12 weeks. Started Sep 2005; status: completed.
02
Drugs
pitavastatin
03
Conditions
hypercholesterolemiacombined dyslipidemia
Beyond the preview
Go deeper on NCT00309777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00309777.